$GTCH Bertagna explained how the COVID-19 pandemic had emphasized and accelerated certain trends in the market, in particular, ones that GTX and GBT are well-positioned to seize upon.
"Our focus, post-pandemic, is to bring to the marketplace solutions that really took grip over the past 18 months," Bertagna said. "Telemedicine, for example, was used, but since the pandemic it has become necessary and vital, just because people couldn't physically see each other. Wearable technology, which is really at the heart of what GTX does, I think is going to see explosive growth over the next five years. Post-pandemic, people are going to want to wear devices that tell them how they're doing, how they're feeling, and will give them the ability to do track-and-trace, monitoring, to see if they've been exposed to other pathogens or ailments."
"We've already outlined and identified three products in the GBT portfolio that would be extremely complimentary to our product offerings and would be very much welcome with our customer base," Bertagna said. "The first one is going to be a low cost, very small tracking technology. Use cases are going to be for pets, children in schools, perhaps for workers on an oil rig or in mines."
"The next product, which we expect in the latter part of the fourth quarter, is going to be a biometrics product." Bertagna explained the increased demand, again accelerated by the experience of the COVID-19 pandemic, for portable health-monitoring devices.
"People are going to want small wearable devices that can give them a lot of information about their health," he said. "We're focusing specifically on four biometric readings, two of which can give a very early indication if you have Covid, the others are blood pressure and heart rate."
"The key to all this is artificial intelligence," Rittman said. "I believe that implementing this type of core technology…can be a complete game changer when it comes to enabling or empowering health-related devices such as wearables.
https://www.benzinga.com/pressreleases/21/06/...nd-how-com
"Our focus, post-pandemic, is to bring to the marketplace solutions that really took grip over the past 18 months," Bertagna said. "Telemedicine, for example, was used, but since the pandemic it has become necessary and vital, just because people couldn't physically see each other. Wearable technology, which is really at the heart of what GTX does, I think is going to see explosive growth over the next five years. Post-pandemic, people are going to want to wear devices that tell them how they're doing, how they're feeling, and will give them the ability to do track-and-trace, monitoring, to see if they've been exposed to other pathogens or ailments."
"We've already outlined and identified three products in the GBT portfolio that would be extremely complimentary to our product offerings and would be very much welcome with our customer base," Bertagna said. "The first one is going to be a low cost, very small tracking technology. Use cases are going to be for pets, children in schools, perhaps for workers on an oil rig or in mines."
"The next product, which we expect in the latter part of the fourth quarter, is going to be a biometrics product." Bertagna explained the increased demand, again accelerated by the experience of the COVID-19 pandemic, for portable health-monitoring devices.
"People are going to want small wearable devices that can give them a lot of information about their health," he said. "We're focusing specifically on four biometric readings, two of which can give a very early indication if you have Covid, the others are blood pressure and heart rate."
"The key to all this is artificial intelligence," Rittman said. "I believe that implementing this type of core technology…can be a complete game changer when it comes to enabling or empowering health-related devices such as wearables.
https://www.benzinga.com/pressreleases/21/06/...nd-how-com
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
